- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.03. | UK health authorities join forces to champion foreign infectious disease trials | ||
| 11.03. | Idorsia and Pharmalink sign agreement to distribute Quviviq | ||
| 11.03. | FDA approves GSK's Wellcovorin for cerebral folate deficiency | ||
| 10.03. | FDA homes in on biosimilar accessibility in new draft guidance | ||
| 10.03. | Junshi receives China's NMPA acceptance for toripalimab injection | ||
| 10.03. | Novo and Hims & Hers become partners to end legal feud | ||
| 10.03. | NewcelX and Eledon partner for NCEL-101 programme | ||
| 09.03. | GSK sells liver disease drug candidate to Alfasigma for $690m | ||
| 09.03. | Vinay Prasad to leave the FDA again | ||
| 09.03. | Sciwind secures China's NMPA approval for Ecnoglutide injection | ||
| 09.03. | BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment | ||
| 06.03. | Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal | ||
| 06.03. | J&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma | ||
| 06.03. | Liberate Bio gains licences for myeloid-specific CAR design patents | ||
| 05.03. | Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit | ||
| 05.03. | CordenPharma leases space at Flatiron Park for peptides development | ||
| 05.03. | Pharmaceutical Technology's parent company GlobalData moves to Main Market of LSE | ||
| 05.03. | Affinia receives FDA fast track designation for AFTX-201 | ||
| 04.03. | Sanofi bets on Sino Biopharm's transplant drug in $1.5bn licensing deal | ||
| 04.03. | Aspire Biopharma and Microsize collaborate for alprazolam powder formulation | ||
| 04.03. | Esperion to acquire Corstasis for cardiovascular franchise expansion | ||
| 03.03. | OSE narrows pipeline focus amid Boehringer MASH collaboration retreat | ||
| 03.03. | Pharma rings the changes as CEO shake-up continues | ||
| 03.03. | Rallybio to acquire Candid Therapeutics | ||
| 03.03. | Novo Nordisk starts €432m Ireland facility upgrade for oral Wegovy production |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.